| Oct 2 |
ADMA Biologics: Riding High On ASCENIV's Success
|
| Sep 30 |
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why
|
| Sep 27 |
Biotech Hangs On To Top Spot On This List, And It Even Outshines Nvidia
|
| Sep 27 |
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
| Sep 26 |
Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024?
|
| Sep 26 |
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why
|
| Sep 26 |
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
|
| Sep 23 |
Millennium Management LLC Acquires Shares in ADMA Biologics Inc
|
| Sep 20 |
Adma Biologics (ADMA) Gains As Market Dips: What You Should Know
|
| Sep 20 |
In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
|
